Stay updated on Effect of Dupilumab on Contact Dermatitis: Clinical Trial
Sign up to get notified when there's something new on the Effect of Dupilumab on Contact Dermatitis: Clinical Trial page.

Latest updates to the Effect of Dupilumab on Contact Dermatitis: Clinical Trial page
- Check4 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1, indicating a backend/UI update with no visible changes to study information or interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoChange DetectedAdded a glossary display option and updated QC metadata labels (including Last Update Submitted that Met QC Criteria) to v3.4.0, with minor capitalization changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page's revision stamp was updated from v3.3.3 to v3.3.4, indicating a maintenance update.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows 'Results Submitted' in place of 'No Results Posted', indicating that results submission is in progress.SummaryDifference0.1%

- Check47 days agoChange DetectedLocations section is added with Massachusetts listed as a site, replacing the previous Massachusetts Locations entry. The footer now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link has been removed.SummaryDifference0.3%

- Check75 days agoChange DetectedRevision: v3.3.2 replaces the previous Revision: v3.2.0 on the study page. The update appears to be administrative and does not alter trial details or eligibility.SummaryDifference0.1%

Stay in the know with updates to Effect of Dupilumab on Contact Dermatitis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Dupilumab on Contact Dermatitis: Clinical Trial page.